Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel D Banister

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
ACS Chemical Neuroscience|January 4, 2021
Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet SyndromeLyndsey L Anderson, Adam Ametovski, Jia Lin Luo, et al.
Journal of Cannabis Research|June 10, 2022
A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel functionCarol J Milligan, Lyndsey L Anderson, Michael T Bowen, et al.
Frontiers in Pharmacology|June 14, 2019
CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor AgonistRichard C Kevin, Lyndsey Anderson, Iain S McGregor, et al.
Frontiers in Psychiatry|January 2, 2023
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11Richard C Kevin, Elizabeth A Cairns, Rochelle Boyd, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2017
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACARichard C Kevin, Katie E Wood, Jordyn Stuart, et al.
Plos One|January 26, 2023
Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndromeLyndsey L Anderson, Dilara A Bahceci, Nicole A Hawkins, et al.
Drug Testing and Analysis|April 4, 2017
Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samplesLukas Mogler, Florian Franz, Daniel Rentsch, et al.
Brain, Behavior, and Immunity|June 1, 2014
Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: amelioration by COX-2 inhibitionKaterina Zavitsanou, Chai K Lim, Tertia Purves-Tyson, et al.
Rapid Communications in Mass Spectrometry : RCM|January 16, 2018
In vitro and in vivo metabolite identification of a novel benzimidazole compound ZLN005 by liquid chromatography/tandem mass spectrometryWenchao Sun, Khoa Dinh Nguyen, William L Fitch, et al.
Forensic Toxicology|January 18, 2023
Characterisation of AMB-FUBINACA metabolism and CB<sub>1</sub>-mediated activity of its acid metaboliteHunter D J Webb, David B Finlay, Shuli Chen, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
ACS Chemical Neuroscience|January 4, 2021
Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet SyndromeLyndsey L Anderson, Adam Ametovski, Jia Lin Luo, et al.
Journal of Cannabis Research|June 10, 2022
A nutraceutical product, extracted from Cannabis sativa, modulates voltage-gated sodium channel functionCarol J Milligan, Lyndsey L Anderson, Michael T Bowen, et al.
Frontiers in Pharmacology|June 14, 2019
CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor AgonistRichard C Kevin, Lyndsey Anderson, Iain S McGregor, et al.
Frontiers in Psychiatry|January 2, 2023
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11Richard C Kevin, Elizabeth A Cairns, Rochelle Boyd, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2017
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACARichard C Kevin, Katie E Wood, Jordyn Stuart, et al.
Plos One|January 26, 2023
Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndromeLyndsey L Anderson, Dilara A Bahceci, Nicole A Hawkins, et al.
Drug Testing and Analysis|April 4, 2017
Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samplesLukas Mogler, Florian Franz, Daniel Rentsch, et al.
Brain, Behavior, and Immunity|June 1, 2014
Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: amelioration by COX-2 inhibitionKaterina Zavitsanou, Chai K Lim, Tertia Purves-Tyson, et al.
Rapid Communications in Mass Spectrometry : RCM|January 16, 2018
In vitro and in vivo metabolite identification of a novel benzimidazole compound ZLN005 by liquid chromatography/tandem mass spectrometryWenchao Sun, Khoa Dinh Nguyen, William L Fitch, et al.
Forensic Toxicology|January 18, 2023
Characterisation of AMB-FUBINACA metabolism and CB<sub>1</sub>-mediated activity of its acid metaboliteHunter D J Webb, David B Finlay, Shuli Chen, et al.
Pageof 9